Drug profile · INN
pandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted)
ADJUPANRIX (PREVIOUSLY PANDEMIC INFLUENZA VACCINE (H5N1) (SPLIT VIRION, INACTIVATED, ADJUVANTED) GLAXOSMITHKLINE BIOLOGICALS)
- Patents linked
- 0
- News articles
- 0
Quick answer
pandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) (ADJUPANRIX (PREVIOUSLY PANDEMIC INFLUENZA VACCINE (H5N1) (SPLIT VIRION, INACTIVATED, ADJUVANTED) GLAXOSMITHKLINE BIOLOGICALS)) is an FDA-listed pharmaceutical active ingredient.
Key facts
Frequently asked questions
What is pandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted)?
pandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) (ADJUPANRIX (PREVIOUSLY PANDEMIC INFLUENZA VACCINE (H5N1) (SPLIT VIRION, INACTIVATED, ADJUVANTED) GLAXOSMITHKLINE BIOLOGICALS)) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for pandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted)?
ADJUPANRIX (PREVIOUSLY PANDEMIC INFLUENZA VACCINE (H5N1) (SPLIT VIRION, INACTIVATED, ADJUVANTED) GLAXOSMITHKLINE BIOLOGICALS) is a marketed brand name for pandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted). Check FDA Drugs@FDA for the current US label holder and prescribing information.